blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4008349

EP4008349 - METHOD FOR TREATING LIVER CANCER WITH COMBINED USE OF REIC/DKK-3 GENE AND ANTI-TUMOR AGENT [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  06.05.2022
Database last updated on 30.10.2024
FormerThe international publication has been made
Status updated on  05.02.2021
Most recent event   Tooltip30.07.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Momotaro-Gene Inc.
Incubator 23
Okayama Medical Innovation Center
5-1, Shikata-cho 2-chome
Kita-ku
Okayama-shi, Okayama 700-8558 / JP
For all designated states
National University Corporation Okayama University
1-1, Tsushima-Naka 1-chome
Kita-ku
Okayama-shi
Okayama 700-8530 / JP
[2022/23]
Inventor(s)01 / KUMON Hiromi
c/o Momotaro-Gene Inc., 1-12-1, Yanagi-machi,
Kita-ku
Okayama-shi, Okayama 700-0904 / JP
02 / SHIRAHA Hidenori
c/o National University Corporation Okayama
University, 1-1, Tsushima-Naka 1-chome, Kita-ku
Okayama-shi, Okayama 700-8530 / JP
03 / OYAMA Atsushi
c/o National University Corporation Okayama
University, 1-1, Tsushima-Naka 1-chome, Kita-ku
Okayama-shi, Okayama 700-8530 / JP
04 / UCHIDA Daisuke
c/o National University Corporation Okayama
University, 1-1, Tsushima-Naka 1-chome, Kita-ku
Okayama-shi, Okayama 700-8530 / JP
05 / IWAMURO Masaya
c/o National University Corporation Okayama
University, 1-1, Tsushima-Naka 1-chome, Kita-ku
Okayama-shi, Okayama 700-8530 / JP
06 / OKADA Hiroyuki
c/o National University Corporation Okayama
University, 1-1, Tsushima-Naka 1-chome, Kita-ku
Okayama-shi, Okayama 700-8530 / JP
 [2022/23]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[2022/23]
Application number, filing date20847959.231.07.2020
[2022/23]
WO2020JP29407
Priority number, dateJP2019014167731.07.2019         Original published format: JP 2019141677
[2022/23]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021020554
Date:04.02.2021
Language:JA
[2021/05]
Type: A1 Application with search report 
No.:EP4008349
Date:08.06.2022
Language:EN
[2022/23]
Search report(s)International search report - published on:JP04.02.2021
(Supplementary) European search report - dispatched on:EP07.08.2023
ClassificationIPC:A61K39/395, A61K45/00, A61K48/00, A61P35/00, A61P43/00, C07K14/47, C12N15/12, C12N15/861, A61K33/24, A61K38/17, A61K31/282, A61K31/44, A61K31/506, A61K31/517, A61K31/5377, A61K31/555, A61K31/7088, A61K35/761
[2022/23]
CPC:
A61P43/00 (EP,CN); A61K48/005 (EP,CN,US); A61K38/1709 (EP,US);
A61K31/282 (CN,US); A61K31/404 (US); A61K31/44 (EP,CN,US);
A61K31/4439 (US); A61K31/47 (EP,US); A61K31/506 (CN,US);
A61K31/517 (CN,US); A61K31/5377 (CN); A61K31/555 (CN);
A61K31/7088 (CN); A61K33/24 (CN); A61K33/243 (EP,US);
A61K38/17 (CN); A61K39/395 (EP); A61K45/06 (EP,CN,US);
A61K48/0075 (CN); A61P35/00 (EP,CN,US); C07K16/2818 (EP);
C12N15/86 (EP); C12N2710/10343 (EP) (-)
C-Set:
A61K31/44, A61K2300/00 (EP);
A61K31/47, A61K2300/00 (EP);
A61K33/243, A61K2300/00 (EP);
A61K38/1709, A61K2300/00 (EP);
A61K39/395, A61K2300/00 (EP)
(-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/23]
TitleGerman:VERFAHREN ZUM BEHANDELN VON LEBERKREBS MIT KOMBINIERTER VERWENDUNG VON REIC/DKK-3 GEN- UND ANTITUMORMITTEL[2022/23]
English:METHOD FOR TREATING LIVER CANCER WITH COMBINED USE OF REIC/DKK-3 GENE AND ANTI-TUMOR AGENT[2022/23]
French:MÉTHODE DE TRAITEMENT DU CANCER DU FOIE À L'AIDE DE L'UTILISATION ASSOCIÉE DU GÈNE REIC/DKK-3 ET D'UN AGENT ANTI-TUMORAL[2022/23]
Entry into regional phase25.02.2022Translation filed 
25.02.2022National basic fee paid 
25.02.2022Search fee paid 
25.02.2022Designation fee(s) paid 
25.02.2022Examination fee paid 
Examination procedure25.02.2022Examination requested  [2022/23]
04.03.2024Amendment by applicant (claims and/or description)
04.03.2024Date on which the examining division has become responsible
Fees paidRenewal fee
25.02.2022Renewal fee patent year 03
27.07.2023Renewal fee patent year 04
30.07.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO2017119499  (MOMOTARO-GENE INC [JP]);
by applicantUS5168062
 US5385839
 WO0138528
 WO2011062298
 WO2012161352
 US2012309050
 US2014147917
 JP2019141677
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.